BIOARRAY Therapeutics
No public posts in this group. You must register or login and become a member in order to post messages, and view any private posts.
Submitted by Chandra Miller ... on Mon, 2011-04-11 07:43
BIOARRAY TherapeuticsDiagnostics for effective cancer treatment sooner . . . because breast cancer affects us all.
Members:
Marcia Fournier, PhD; CEO, Founder
Katherine Martin, PhD; CSO, Founder
Chandra Miller Fienen; JD, Founder
David Magee, PhD, VP
|
Industry Focus:
Life Sciences/Healthcare
|
About
BIOARRAY Therapeutics is developing innovative molecular diagnostic tests that help women with breast cancer and their doctors identify more effective treatment sooner by predicting chemotherapy response across multiple cancer subtypes. Our test will help reduce the present "trial and error" approach to chemotherapy treatment decisions, helping patients while reducing overall treatment costs.
4.938775
Your rating: None Average: 4.9 (98 votes)
@bioarray_cmf
-
bioarray_cmf Interesting study about 1 in 3 lumpectomies being repeated. NYTimes: Breast Cancer Surgery Rules Are Called Unclear t.co/7y9tK1mp

-
bioarray_cmf @komenforthecure this is the sort of thing BIOARRAY is hoping to help with

-
bioarray_cmf How do Boston startups compare on AngelList? Not stellar t.co/Bc5GKBoh via @BBJNewsroom

-
bioarray_cmf BIOARRAY -- in the right place at the right time in Brazil. More at: t.co/3uFJ7IgA



